Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 Lymphoid 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 CNS 1

Conditions

Leukemia, B-Cell 1

Interventions

venetoclax 136 Cytarabine 106 Cyclophosphamide 104 Specimen Handling 94 fludarabine 86 Azacitidine 84 Biopsy 71 Rituximab 45 Methotrexate 42 Daunorubicin 41 fludarabine phosphate 40 Vincristine 35 Magnetic Resonance Spectroscopy 35 Dexamethasone 35 blinatumomab 31 Injections 31 Decitabine 31 Granulocyte Colony-Stimulating Factor 29 Mycophenolic Acid 28 Whole-Body Irradiation 27 Idarubicin 27 ibrutinib 26 Tacrolimus 26 Prednisone 26 Etoposide 26 Busulfan 25 Melphalan 24 Doxorubicin 24 acalabrutinib 23 Calcium Dobesilate 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Diet × Other hematologic neoplasm × 90 days × Clear all

NCT07487428 2026-03-23

CLL-IMPACT

Technical University of Munich

Phase NA Recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡